Schedule 13G ownership disclosure
Eleven Biotherapeutics, Inc.
Security class unavailable · CUSIP: 286221106
Event date: 2016-01-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,061,999
- Percent of class
- 5.4200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-16-000139
- Form type
- SC 13G
- Filer
- Carisma Therapeutics Inc.
- CIK
- CIK 1485003
- Filed
- Feb 01, 2016
- Reporting period
- Jan 26, 2016
- Description
- Schedule 13G beneficial ownership